Related references
Note: Only part of the references are listed.Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer
Wenna Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
miR-153 enhances the therapeutic effect of radiotherapy by targeting JAG1 in pancreatic cancer cells
Zhibin Zhao et al.
ONCOLOGY LETTERS (2021)
An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
Zengyu Feng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
Chuming Tao et al.
FRONTIERS IN ONCOLOGY (2020)
ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer
Tim D. D. Somerville et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer
Jungwhoi Lee et al.
CELLULAR ONCOLOGY (2020)
LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity
Hui Wang et al.
EXPERIMENTAL CELL RESEARCH (2020)
COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
Kwabena Gyabaah Owusu-Ansah et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy
Nicolas Macias et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
Support vector machine classifier for prediction of the metastasis of colorectal cancer
Jiajun Zhi et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods
Chunyang Li et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine
Nancy A. Obuchowski et al.
PHYSICS IN MEDICINE AND BIOLOGY (2018)
Prospects for new lung cancer treatments that target EMT signaling
Yuji Otsuki et al.
DEVELOPMENTAL DYNAMICS (2018)
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M. Krebs et al.
NATURE CELL BIOLOGY (2017)
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Oliver G. McDonald et al.
NATURE GENETICS (2017)
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
David J. Birnbaum et al.
BMC MEDICINE (2017)
HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells
Shu Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients
Ye Chen et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
Dung-Tsa Chen et al.
PLOS ONE (2015)
An immunotherapeutic intervention against tumor progression Targeting a driver of the epithelial-to-mesenchymal transition
Claudia Palena et al.
ONCOIMMUNOLOGY (2014)
S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells
Sayka Barry et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma
Jean-Baptiste Bachet et al.
EUROPEAN JOURNAL OF CANCER (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic Adenocarcinoma
Nina V. Chaika et al.
PLOS ONE (2012)
L1 Penalized Estimation in the Cox Proportional Hazards Model
Jelle J. Goeman
BIOMETRICAL JOURNAL (2010)
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Jeran K. Stratford et al.
PLOS MEDICINE (2010)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis
K. Ohuchida et al.
JOURNAL OF PATHOLOGY (2007)
Share Paper
